LP-1s are no longer only useful for weight loss and diabetes they are critical for building metabolic resilience and reducing inflammation. Dr
[DOI] [PubMed] [Google Scholar] 157.Day J.W., Gelfanov V., Smiley D., Carrington P.E., Eiermann G., Chicchi G., Erion M.D., Gidda J., Thornberry N.A., Tschp M.H., et al
Hair loss with GLP-1 drugs is rare, but real, studies find By Nancy Lapid July 22 (Reuters) - The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, new studies suggest
Important Considerations & Safety Matters Not FDA-approved as a commercial drug : Because this is a compounded product (versus a brand-manufactured medication), its not subject to the same FDA review for safety/efficacy
Therefore, inhibition of NF- promotes an anti-inflammatory response, which could influence the redox status and immune microenvironment of the tumor [28,33]
NRF2 is a key regulator of endothelial microRNA expression under proatherogenic stimuli